Effects of valproic acid on transcript levels in neurotrophin signaling pathway in mice hippocampus according to the implementation period

1 Chateauvieux S, Morceau F, Dicato M, Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010; 2010. Search in Google Scholar

2 Macfarlane A, Greenhalgh T. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? BMC Pregnancy Childbirth 2018; 18: 1-11. Search in Google Scholar

3 Hill DS, Wlodarczyk BJ, Palacios AM, Finnell RH. Teratogenic effects of antiepileptic drugs. Expert Rev Neurother 2010; 10: 943-59. Search in Google Scholar

4 Tanoshima M, Kobayashi T, Tanoshima R, Beyene J, Koren G, Ito S. Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis. Clin Pharmacol Ther 2015; 98: 417-41. Search in Google Scholar

5 Koren G, Nava-Ocampo AA, Moretti ME, Sussman R, Nulman I. Major malformations with valproic acid. Can Family Phys 2006; 52: 441-2. Search in Google Scholar

6 Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacol 2005; 30: 80-9. Search in Google Scholar

7 Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol 2018; 299: 217-27. Search in Google Scholar

8 Kim KC, Kim P, Go HS, et al. The critical period of valproate exposure to induce autistic symptoms in Sprague–Dawley rats. Toxicol Lett 2011; 201: 137-42. Search in Google Scholar

9 Almeida LE, Roby CD, Krueger BK. Increased BDNF expression in fetal brain in the valproic acid model of autism. Mol Cell Neurosci 2014; 59: 57-62. Search in Google Scholar

10 Miyazaki K, Narita N, Sakuta R, et al. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 2004; 26: 292-5. Search in Google Scholar

11 Dinçel N, Ünalp A, Kutlu A, Öztürk A, Uran N, Ulusoy S. Serum nerve growth factor levels in autistic children in Turkish population: a preliminary study. Indian J Med Res 2013; 138: 900. Search in Google Scholar

12 Nelson KB, Grether JK, Croen LA, et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001; 49: 597-606. Search in Google Scholar

13 Pancheva R, Georgieva M. Autism spectrum disorders: neurotrophins enter the dance. Biomed Rev 2014; 25: 93-9. Search in Google Scholar

14 Tsai S-J. Is autism caused by early hyperactivity of brain-derived neurotrophic factor? Med Hypotheses 2005; 65: 79-82. Search in Google Scholar

15 Correia C, Coutinho A, Sequeira A, et al. Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes, Brain and behavior 2010; 9: 841-8. Search in Google Scholar

16 Leal G, Bramham C, Duarte C. BDNF and hippocampal synaptic plasticity. Vitam Horm 2017; 104: 153-95. Search in Google Scholar

17 Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory? Front Mol Neurosci 2010; 3: 1. Search in Google Scholar

18 Iughetti L, Lucaccioni L, Fugetto F, Predieri B, Berardi A, Ferrari F. Brain-derived neurotrophic factor and epilepsy: a systematic review. Neuropeptides 2018; 72: 23-9. Search in Google Scholar

19 Noh H, Seo H. Age-dependent effects of valproic acid in Alzheimer’s disease (AD) mice are associated with nerve growth factor (NGF) regulation. Neuroscience 2014; 266: 255-65. Search in Google Scholar

20 Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996; 370: 247-61. Search in Google Scholar

21 Markram K, Rinaldi T, Mendola DL, Sandi C, Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacol 2008; 33: 901-12. Search in Google Scholar

22 Morakotsriwan N, Wattanathorn J, Kirisattayakul W, Chaisiwamongkol K. Autistic-like behaviors, oxidative stress status, and histopathological changes in cerebellum of valproic acid rat model of autism are improved by the combined extract of purple rice and silkworm pupae. Oxid Med Cell Longev 2016; 2016. Search in Google Scholar

23 Reynolds S, Millette A, Devine DP. Sensory and motor characterization in the postnatal valproate rat model of autism. Dev Neurosci 2012; 34: 258-67. Search in Google Scholar

24 Gedzun V, Dubynin V, Malyshev A, Sarycheva N, Svinov M. Comparing models of autism spectrum disorder based on pre-and postnatal valproate exposure: behavioral and histological assessment. Eur Neuropsychopharmacol 2017; 27: S679-S80. Search in Google Scholar

25 Wang C-Y, Cheng C-W, Wang W-H, Chen P-S, Tzeng S-F. Postnatal stress induced by injection with valproate leads to developing emotional disorders along with molecular and cellular changes in the hippocampus and amygdala. Mol Neurobiol 2016; 53: 6774-85. Search in Google Scholar

26 Elnahas EM, Abuelezz SA, Mohamad MI, Nabil MM, Abdelraouf SM, Bahaa N, et al. Validation of prenatal versus postnatal valproic acid rat models of autism: a behavioral and neurobiological study. Prog Neuropsychopharmacol Biol Psychiatry 2021; 108: 110185. Search in Google Scholar

27 OECD, Test No. 424: Neurotoxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, 1997. https://doi.org/10.1787/9789264071025-en. Search in Google Scholar

28 Ozkul Y, Taheri S, Bayram KK, Sener EF, Mehmetbeyoglu E, Öztop DB, et al. A heritable profile of six miRNAs in autistic patients and mouse models. Sci Rep 2020; 10: 1-14. Search in Google Scholar

29 Ye T, Meng X, Wang R, et al. Gastrodin alleviates cognitive dysfunction and depressive-like behaviors by inhibiting ER stress and NLRP3 inflammasome activation in db/db mice. International J Mol Sci 2018; 19: 3977. Search in Google Scholar

30 Ikeda K, Sato A, Mizuguchi M. Social interaction test: a sensitive method for examining autism-related behavioral deficits. 2013. Search in Google Scholar

31 Moy SS, Nadler JJ, Poe MD, et al. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008; 188: 178-94. Search in Google Scholar

32 Ho Y-J, Eichendorff J, Schwarting RK. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 2002; 136: 1-12. Search in Google Scholar

33 Nicolas LB, Kolb Y, Prinssen EP. A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol 2006; 547: 106-15. Search in Google Scholar

34 Hedlund PB, Sutcliffe JG. The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett 2007; 414: 247-51. Search in Google Scholar

35 Dekeyne A. Behavioural models for the characterization of established and innovative antidepressant agents. Therapies 2005; 60: 477-84. Search in Google Scholar

36 Shimazaki T, Iijima M, Chaki S. Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test. Eur J Pharmacol 2004; 501: 121-5. Search in Google Scholar

37 Pinel JP, Treit D. Burying as a defensive response in rats. J Comp Psychol 1978; 92: 708. Search in Google Scholar

38 Kaidanovich-Beilin O, Lipina T, Vukobradovic I, Roder J, Woodgett JR. Assessment of social interaction behaviors. JoVE (Journal of Visualized Experiments) 2011: e2473. Search in Google Scholar

39 Deacon RM, Rawlins JNP. Hippocampal lesions, species-typical behaviors and anxiety in mice. Behav Brain Res 2005; 156: 241-9. Search in Google Scholar

40 Taheri S, Karaca Z, Rassoulzadegan M, et al. The characterization of sex differences in hypoglycemia-induced activation of HPA axis on the transcriptomic level. Cell Mol Neurobiol 2022; 42: 1523-42. Search in Google Scholar

41 Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001;25(4),402–408. https://doi.org/10.1006/meth.2001.1262 Search in Google Scholar

42 Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Ann Rev Neurosci 2001; 24: 677. Search in Google Scholar

43 Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci 2006; 110: 175-91. Search in Google Scholar

44 Shelton DL, Reichardt LF. Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Nat Acad Sci 1986; 83: 2714-8. Search in Google Scholar

45 Koliatsos VE, Clatterbuck RE, Nauta HJ, et al. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 1991; 30: 831-40. Search in Google Scholar

46 Auld DS, Mennicken F, Quirion R. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences. J Neurosci 2001; 21: 3375-82. Search in Google Scholar

47 Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol 1994; 350: 587-611. Search in Google Scholar

48 Conner JM, Franks KM, Titterness AK, et al. NGF is essential for hippocampal plasticity and learning. J Neurosci 2009; 29: 10883-9. Search in Google Scholar

49 Clemow DB, Steers WD, Tuttle JB. Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats. J Cell Physiol 2000; 183: 289-300. Search in Google Scholar

50 Guney E, Ceylan MF, Kara M, et al. Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD). Neurosci Lett 2014; 560: 107-11. Search in Google Scholar

51 Klein R, Nanduri V, Jing S, et al. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991; 66: 395-403. Search in Google Scholar

52 Klein R, Lamballe F, Bryant S, Barbacid M. The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 1992; 8: 947-56. Search in Google Scholar

53 Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B: Biol Sci 2006; 361: 1545-64. Search in Google Scholar

54 Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309-13. Search in Google Scholar

55 Smith WW, Norton DD, Gorospe M, et al. Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity. J Cell Biol 2005; 169: 331-9. Search in Google Scholar

56 Bashir M, Parray AA, Baba RA, et al. Β-amyloid-evoked apoptotic cell death is mediated through MKK6–p66shc pathway. Neuromolecular Med 2014; 16: 137-49. Search in Google Scholar

57 Berry A, Capone F, Giorgio M, et al. Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol 2007; 42: 37-45. Search in Google Scholar

58 Berry A, Greco A, Giorgio M, et al. Deletion of the lifespan determinant p66Shc improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice. Exp Gerontol 2008; 43: 200-8. Search in Google Scholar

59 Camici GG, Schiavoni M, Francia P, et al. Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Nat Acad Sci 2007; 104: 5217-22. Search in Google Scholar

60 Francia P, delli Gatti C, Bachschmid M, et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004; 110: 2889-95. Search in Google Scholar

61 Napoli C, Martin-Padura I, De Nigris F, et al. Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Nat Acad Sci 2003; 100: 2112-6. Search in Google Scholar

62 Betts DH, Bain NT, Madan P. The p66Shc adaptor protein controls oxidative stress response in early bovine embryos. PloS one 2014; 9: e86978. Search in Google Scholar

63 Yamashita H, Avraham S, Jiang S, Dikic I, Avraham H. The Csk homologous kinase associates with TrkA receptors and is involved in neurite outgrowth of PC12 cells. J Biol Chem 1999; 274: 15059-65. Search in Google Scholar

64 Kuo SS, Armanini MP, Phillips HS, Caras IW. Csk and BatK show opposite temporal expression in the rat CNS: consistent with its late expression in development, BatK induces differentiation of PC12 cells. Eur J Neurosci 1997; 9: 2383-93. Search in Google Scholar

65 Lacal JC, Campos JM. Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer CellsPreclinical Profile of Choline Kinase Alpha Inhibitors. Mol Cancer Ther 2015; 14: 31-9. Search in Google Scholar

66 Klöckner C, Fernández-Murray JP, Tavasoli M, et al. Biallelic variants in CHKA cause a neurodevelopmental disorder with epilepsy and microcephaly. Brain 2022; 145: 1916-23. Search in Google Scholar

67 Nguyen TL, Kim CK, Cho J-H, Lee K-H, Ahn J-Y. Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7 cells. Exp Mol Med 2010; 42: 583-95. Search in Google Scholar

68 Desfossés-Baron K, Hammond-Martel I, Simoneau A, Sellam A, Roberts S, Wurtele H. Valproate inhibits MAP kinase signalling and cell cycle progression in S. cerevisiae. Sci Rep 2016; 6: 1-14. Search in Google Scholar